Advanced Search

 

Study ID Status Title Patient Level Data
111670 Completed Long-term antibody persistence of GSK Biologicals' MenACWY-TT vaccine versus Menactra® in healthy adolescents/adults aged 10-25 years and booster response to MenACWY-TT vaccine administered at 5 years post-primary vaccination
111676 Terminated A double blind, double dummy, placebo controlled cross over study with a positive control to investigate the effect of a GSK drug on electrical hyperalgesia and threshold tracking in healthy subjects
111679 Completed Efficacy and safety of HIV Vaccine 732462 in ART-naïve HIV-1 infected persons
111680 Completed An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Digoxin When Coadministered With Albiglutide in Healthy Adult Subjects Study Listed on ClinicalStudyDataRequest.com
111681 Completed An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Warfarin When Coadministered With Albiglutide in Healthy Adult Subjects Study Listed on ClinicalStudyDataRequest.com
111684 Completed Analysis of expression of antigens in bone marrow samples from volunteering donors.
111687 Completed An Open-Label Study to Investigate the Pharmacodynamics of a Repeat Dose Regimen of Bevacizumab (10 mg/kg q2w) and Escalating Repeat Doses of Pazopanib in Renal Cell Carcinoma
111700 Completed Safety of GlaxoSmithKline Biologicals’ oral live attenuated human rotavirus vaccine, Rotarix™ or Rotarix™ liquid formulation (oral suspension or prefilled syringe) when administered according to the prescribing information in Korea
111709 Completed Study in healthy children of GSK Biologicals’ DTPa-IPV/Hib-MenC-TT vaccine, GSK2197870A, co-administered with Prevenar™ as a three-dose primary vaccination course in infancy followed by a booster dose of Menitorix™ at 12 months of age Study Listed on ClinicalStudyDataRequest.com
111712 Completed Safety study of GSK Biologicals’ human papillomavirus vaccine (GSK-580299) in healthy female subjects. Study Listed on ClinicalStudyDataRequest.com
111714 Terminated Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in association with chemotherapy in patients with unresectable and progressive metastatic cutaneous melanoma
111716 Completed A Phase I, Open-label, Single Sequence, Crossover Study Evaluating the Safety and the Pharmacokinetics of Lopinavir/Ritonavir and Eltrombopag Given Alone and when Co-administered in Healthy Adult Subjects.
111718 Completed A randomized, open-label, five-period, balanced crossover study to evaluate the relative bioavailability of an eltrombopag Powder for Oral Suspension (PfOS) formulation relative to the commercial 25 mg tablet formulation and to evaluate administration of the PfOS formulation with and separated 2 hours from a high calcium meal in healthy adult subjects
111720 Completed Quality of Life(QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatment
111722 Completed Analysis of the incidence of expression of a specific set of genes and of tumor antigens in cancer tissue from patients with hepatocellular carcinoma
111726 Completed Analysis of the incidence of expression of tumor antigens and tumor marker in cancer tissue from Asian patients with hepatocellular carcinoma and evaluation of prognostic significance of these tumor antigens.
111727 Completed Study of GSK2130579A Tumor-Antigen-Specific Cancer Immunotherapeutic in adult Acute Myeloid Leukemia patients with a suboptimal clinical response to induction chemotherapy
111729 Completed A trial to evaluate the safety & immunogenicity of investigational influenza vaccine GSK1557484A in adults 18-64 yrs of age Study Listed on ClinicalStudyDataRequest.com
111733 Terminated A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects with Major Depressive Disorder
111736 Completed Vaccination course in children primed and boosted with pneumococcal vaccine GSK 1024850A and in age-matched unprimed children Study Listed on ClinicalStudyDataRequest.com
111737 Completed Observer-blind safety and immunogenicity study of GlaxoSmithKline Biologicals’ influenza vaccine GSK2186877A when administered to elderly subjects. Study Listed on ClinicalStudyDataRequest.com
111738 Completed Safety and immunogenicity of the influenza vaccine GSK2186877A in the elderly Study Listed on ClinicalStudyDataRequest.com
111751 Completed Immunogenicity and safety of GSK Biologicals’ thimerosal-free TIV flu vaccine versus a licensed comparator in children Study Listed on ClinicalStudyDataRequest.com
111752 Terminated An open-label, international, multi-center, phase II, extension trial investigating long-term efficacy and safety of repeated treatment courses of ofatumumab, a fully human monoclonal anti-CD20 antibody, in adult patients with active rheumatoid arthritis who previously received ofatumumab or placebo
111756 Completed Immunogenicity and safety of GSK Biologicals’ (pre-) pandemic influenza candidate vaccine GSK 1557484A. Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.